Introduction
============

The retina is well known for its high rate of energy consumption \[[@r1]\]. Oxygen delivery to the photoreceptors in the outer retina differs from that in other nervous tissues, in that oxygen is provided by diffusion from the choroidal circulation, which requires very high levels of blood flow \[[@r1],[@r2]\]. There is no local coupling between metabolic expenditures of photoreceptors and blood flow in the choroidal vessels, and therefore oxygen tension can decrease to low levels at the proximal side of the inner segment in the face of high energy expenditures during dark-adaptation \[[@r2]\]. Furthermore, photoreceptor function is rapidly affected after the onset of hypoxia \[[@r2]\]. The expression of the oxygen-storage molecule, neuroglobin, in the photoreceptor inner segment further underlines the importance of regulation of oxygen availability \[[@r3]\]. Importantly, chronic ischemia-hypoxia of the rat retina, induced by occlusion of both common carotid arteries, can be associated with photoreceptor degeneration \[[@r4],[@r5]\]. We have shown in rats that such photoreceptor degeneration will occurr with a delay of several weeks to months after occlusion of both common carotid arteries \[[@r6]\]. Thus, metabolic failure and oxidative stress may be related to slow degeneration of photoreceptors in rodent models of ocular ischemia \[[@r5]\].

Several studies have suggested that the high rate of oxygen consumption of photoreceptors is involved in the vulnerability to retinitis pigmentosa (RP) \[[@r1],[@r7]-[@r11]\]. Such interaction could be quite general, in that moderately dysfunctional photoreceptors carrying RP mutations in a variety of cell-specific genes could be prone to undergo apoptosis when challenged with transient energetic deficits, e.g., due to changes in membrane function and calcium homeostasis \[[@r11]\]. The link could also be more specific through regulation of gene expression in response to the state of oxygenation. For example, the *RP1* gene was identified as oxygen-regulated photoreceptor protein 1 (ORP1) when retinal gene expression was studied under conditions of hypoxia \[[@r12]\]. Bernstein et al. noted that the expression of a given disease causing gene within the retina may not be selective for the cells affected by degeneration \[[@r13]\]. Furthermore, mutations in ten genes cause retina-specific degeneration although these genes are also expressed in several other organs, i.e., the RP9 gene *PAP1, IMPDH, MERTK, RPGR, RP2, CHM, TIMP3*, and three pre-mRNA splicing factors \[[@r14]\]. Retina-specific splice variants and high expression of the gene in the retina relative to other organs may explain the selective vulnerability in the case of *IMPDH1* mutations in RP10 \[[@r15],[@r16]\]. Selective expression of a critical binding partner in the retina is another possible scenario \[[@r16]\]. In this paper, we postulate that widely expressed genes causing RP may be components of protein complexes whose function is dependent on oxygenation through regulation of gene expression and that the cyclical character of oxygenation in the outer retina introduces a selective deleterious effect on photoreceptors. Thereby, we will primarily use the term "hypoxia" to indicate a critically low level of oxygenation, whereas abnormally high levels of oxygen and oxidative stress may as well be involved \[[@r10]\].

Selective degeneration of photoreceptor cells is found in autosomal dominant retinitis pigmentosa (ADRP) associated with mutations in genes coding for proteins involved in pre-mRNA splicing in the spliceosome. This selectivity for the retina is striking, because the genes involved are house keeping genes \[[@r14],[@r16]\]. RP11 (OMIM [600138](http://www.molvis.org/molvis/external.cgi?omim=600138)) is associated with mutations in precursor mRNA-processing factor 31 (*PRPF31*) \[[@r17]-[@r19]\]; RP13 (OMIM [600059](http://www.molvis.org/molvis/external.cgi?omim=600059)) with precursor mRNA-processing factor 8 (*PRPF8*) mutations \[[@r20]\]; and RP18 (OMIM [601414](http://www.molvis.org/molvis/external.cgi?omim=601414)) with precursor mRNA-processing factor 3 (*PRPF3*) mutations \[[@r21]\]. PRPF31 and PRPF3 are protein components of the U4/U6 small nuclear ribonucleoprotein (snRNP) complex, and PRPF8 is the core component of the U5 snRNP \[[@r14],[@r16]\]. Additionally, although the evidence is not as strong, mutations in Pim1 kinase associated protein (*PAP1*) were found to cause RP9 (OMIM [607331](http://www.molvis.org/molvis/external.cgi?omim=607331)) \[[@r22]\]. PAP1 has also been characterized as a component of the U4/U6.U5 tri-snRNP complex, which interacts with PRPF3 \[[@r23],[@r24]\]. These four proteins (PRPF31, PRPF8, PRPF3, PAP1) contribute to the formation and function of the U4/U6.U5 tri-snRNP complex, which involves at least thirty proteins \[[@r14],[@r16]\]. Although pre-mRNA splicing should be important for all cells in the body, only photoreceptor cell death occurs in these four forms of ADRP. There is no evidence in the literature that retina-specific splice variants exist for these genes. Haploinsufficiency has been proposed as the pathogenic factor in ADRP \[[@r16],[@r18]\], especially for *PRPF31* (RP11) \[[@r17],[@r25]-[@r27]\]. One scenario for the selective vulnerability of photoreceptors is quantitative, the regulation of splicing is necessary for photoreceptors because the levels of mRNA for rhodopsin (and perhaps other genes) undergo considerable change due to the circadian rhythm \[[@r18],[@r21],[@r26]\]. Recently, photoreceptor genes affected by *PRPF31* mutations have been reported \[[@r28]\]. Other studies have shown changes in nuclear trafficking caused by a reduced solubility of mutant *PRPF31* \[[@r29]\]. Mutant PRPF3 associated with RP differed from the wild type protein by forming abnormally big protein aggregates in transfected photoreceptor cells, and aggregation of mutant *PRPF3* inside the nucleus triggered apoptosis in photoreceptor cells \[[@r30]\]. Yeast two-hybrid analyses have suggested a link between RP and an aberrant hPrp31-hPrp6 interaction that blocks U4/U6-U5 tri-snRNP formation \[[@r31]\]. In the present study, we examined the hypothesis that the function of the U4/U6.U5 tri-snRNP complex is oxygen regulated because of the energy dependence of splicing \[[@r32]\], and that this mechanism provides specificity for the effects of the mutation on the outer retina.

Using a theoretical approach, we have previously explored links between the genetics of nervous system disorders and oxygen regulation of gene expression \[[@r33]\]. We compiled a listing of genes regulated by ischemia-hypoxia in the rodent brain from a detailed evaluation of microarray studies and the original literature, and correlated this list with a set of candidate genes for schizophrenia \[[@r33]\]. At present, the information for gene expression changes in ischemia-hypoxia in the retina \[[@r34]\] is too limited to perform a similar analysis for genetic disorders of the retina. It has been proposed that gene expression related to fundamental pathological events in the brain and retina should be sufficiently similar, so that data collections can be carried over from the brain to the retina in a theoretical approach \[[@r35]\]. Such strategy could be especially fruitful for globally expressed RP genes as discussed in the preceding text. In this paper, we used the brain-based database and literature searches to look for potential connections between globally expressed RP genes and changes in oxygenation with a specific focus on pre-mRNA splicing. We identified four genes involved in the U4/U6.U5 tri-snRNP of the spliceosome during this search. Databases for retinal gene expression were then used to confirm the expression of these genes. Finally, immunohistochemistry was used to identify the protein expressed by one of the four genes in the monkey and human retina.

Methods
=======

Stage A
-------

We built a database of 24 published gene expression studies in brain ischemia-hypoxia, starting with our cDNA microarray study of focal brain ischemia \[[@r36]\]. Gene lists were transformed into an Excel (Microsoft) datasheet, and genes were identified by running clone identification numbers for individual probes through Nucleotide, UniGene, and Entrez Gene (NCBI). Selected probes of the microarray analysis were verified by using BLAST searches (Nucleotide, NCBI). We generated an ischemia-hypoxia response (IHR) gene list after sorting by gene symbol and removing redundancy. Information for individual genes was retrieved from OMIM (NCBI) and the literature (PubMed, NCBI). Genes were collected under different categories that were defined by mechanisms of ischemic-hypoxic cell damage and neurodegeneration. Two studies relevant to hypoxia regulation in neurons by hypoxia inducible factor 1 and 2 (HIF-1, HIF-2) were considered in addition \[[@r37],[@r38]\]. Information for gene expression studies in retinal ischemia was searched using PubMed, but only one data set \[[@r34]\] was found to be in parallel with the IHR gene list. We also reprobed the original data set of our microarray study \[[@r36]\] for specific genes encountered during the search.

Stage B
-------

UniGene and PubMed searches were used to test whether widely expressed RP genes were also found in the brain. A listing of RP genes with widespread expression and function were taken from the review of Pacione et al. \[[@r14]\]: *RP9/PAP1, IMPDH1, MERTK, RPGR, RP2, CHM, TIMP3*, and three pre-mRNA splicing factors. An update was performed, using database searches the Retinal Information Network ([RetNet](http://www.sph.uth.tmc.edu/RetNet)) and the Retina International Scientific Newsletter ([RISN](http://www.retina-international.com/sci-news/)), which led to the addition of *SEMA4A* \[[@r39]\] and *CA4* \[[@r40]\]. The analysis of brain expression aimed at globally expressed genes involved in RP and was not designed as a comprehensive study of brain expression of all RP genes.

Stage C
-------

The IHR gene list was then searched for genes involved in RP and related retinal dystrophies. Gene symbols were run through OMIM to see whether a role in specific ophthalmic diseases was listed or if the gene was under consideration as a risk gene. Lists in RetNet and RISN were regularly surveyed for matches to ischemia-hypoxia regulated genes. Several retina-specific disease genes were found oxygen regulated, and one RP-interacting gene involved in pre-mRNA splicing (RP9 see Results) was retrieved.

Stage D
-------

We then focused on genes related to pre-mRNA splicing in the IHR gene list, because of the unique overpresentation of genes of the U4/U6.U5 tri-snRNP complex among widely expressed RP genes \[[@r14]\], the expression of these genes in the brain as documented at Stage B, and the finding of one gene related to pre-mRNA splicing and RP at Stage C (see Results). IHR genes related to mRNA processing were identified, and specific links to the U4/U6.U5 tri-snRNP were explored using information available through Entrez Gene, OMIM, and PubMed. The purpose of this analysis was to identify relations between the hypoxia regulation and pre-mRNA splicing, i.e., oxygen dependence of genes interacting with the RP genes in the spliceosome.

Stage E
-------

To analyze the expression of genes identified during Stage D in the human retina, a database search for mRNA in [NEIBank](http://neibank.nei.nih.gov/index.shtml) at the National Eye Institute was carried out. Gene expression profiles in the mouse retina were examined using serial analysis of gene expression (SAGE) derived databases \[[@r41]\]. The EyeBrowse ([Browse](http://eyebrowse.cit.nih.gov/)) database was also used. This database provides an alignment of eye specific ESTs with the human genome sequence according to the Genome Browser (UCSC). Studies with immunohistochemistry for a selected protein are described in Stage H.

Stage F
-------

Bioinformatics were used to identify target genes regulated by HAF (i.e., *SART1*), which is one of the oxygenation-regulated members of the U4/U6.U5 tri-snRNP complex (see Results). The EP17 consensus sequence (5′-CCC CCA CCC CCA CCC GC-3′) for HAF binding in the promoter of the *EPO* gene \[[@r42]\] was used in a BLAST (NCBI) search for "short nearly exact matches." Only fully annotated genes and hits on putative regulatory regions were evaluated. Published information was retrieved to connect such genes to retinal function and pathology.

Stage G
-------

This study was conducted after approval of a protocol by the Animal Care and Use Committee and Review Board for Animal Research of the University of Miami and conformed to the Statement for the Use of Animals in Ophthalmic and Vision Research by the Association for Research in Vision and Ophthalmology (ARVO). Whole eye globes were provided in accordance with a university-wide ACUC approved Tissue Sharing Protocol. Whole eyes of two year old, healthy, male cynomolgus monkeys (*Macaca fascicularis*) were received immediately after euthanasia and the posterior pole was dissected less than 2 h postmortem, immediately fixed by immersion in 10% buffered formalin for 16 h, and then transferred to phosphate buffered saline (PBS). The retinas of n=3 monkeys were processed the immunohistochemical study (supplementing stage E of the analysis). The tissue were embedded in paraffin, and sections were cut with a microtome to 8 μm thickness, then mounted on glass slides coated with poly-L-lysine (Sigma-Aldrich, St. Louis, MO). Immunohistochemistry was performed employing the avidin-biotin (ABC) technique using antigen retrieval with microwave treatment \[[@r6]\]. Sections were rinsed with PBS, then incubated in 0.3% H~2~O~2~ for 15 min to inactivate endogenous peroxidase and then blocked with 10% normal goat serum, 0.25% Triton X-100, and Avidin D solution (Avidin/Biotin blocking kit, Vector, Burlingame, CA) for 30 min. Next sections were washed with 0.25% Triton X-100 in PBS and incubated in PBS containing 0.25% of Triton X-100, biotin solution (avidin/biotin blocking kit, Vector), 1% normal goat serum, and the primary antibody for 1 h at room temperature. Affinity-purified rabbit antibodies to an N-terminal sequence of the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP were kindly provided by Drs. Olga V. Makarova and Evgeny M. Makarov, and Prof. R. Luehrmann, Department of Cellular Biochemistry, Max-Planck-Institute for Biophysical Chemistry, Goettingen, Germany \[[@r43]\]. Antibodies were applied at a dilution of 1:200. Sections were washed with 0.25% Triton X-100 in PBS and treated with biotin-conjugated goat anti-rabbit IgG (1:250; BA-1000; Vector) followed by streptavidin-HRP (K0377; Dako, Carpintera, CA). Diaminobenzidine (0.05%) including 0.003% H~2~O~2~ was used for the permanent localization of peroxidase activity. Omission of the primary antibody and absorption with the native immunogenic peptide served as control. Sections were dehydrated in a series of alcohols and xylene, and coverslipped with DePeX (Aldrich, Milwaukee, WI). Some sections were counterstained with hematoxylin to visualize the nucleus.

Retinal specimens from a 46 year old female donor became available (University of Regensburg, Germany) within 1 h after enucleation due to severe herpes simplex keratitis. The tissue was fixed in 4% paraformaldehyde in PBS (pH 7.4) overnight at 4 °C. Specimens were embedded in paraffin, and sections were cut at 2 μm with a microtome, then fixed on Superfrost® plus glass slides (Menzel, Braunschweig, Germany). Immunohistochemistry was performed with a modified ABC technique, using antigen retrieval with microwave treatment. Sections were incubated in citric acid/citrate buffer (0.2 mM citric acid, 9.8 mM sodium citrate, pH 7.3) for 2 min at 800 W and then 10 min at 240 W in a microwave oven. The rabbit antibody to an N-terminal sequence of the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP was applied in a 1:200 dilution and incubated using Shandon Coverplates (Thermo, Pittsburgh, PA) and the DakoCytomation LSAB2 System-HRP (K0672, DakoCytomation, Carpinteria, CA) according to the manufacturers\' instructions. Primary antibody absorbed with the native peptide served as control. Sections were dehydrated and coverslipped with Entellan new (Merck, Darmstadt, Germany).

Stage H
-------

Based on the matches found for pre-mRNA splicing (see Results), it was considered whether other RP forms may involve genes related to pre-mRNA splicing. Genes identified at Stage D were analyzed. Human, mice and dog gene loci were retrieved from the Genome Browser and OMIM. Chromosomal localizations were checked in the RISN for related retinal dystrophies and for RP forms in which the underlying gene has not yet been identified. The literature \[[@r44],[@r45]\] and the RISN animal database were searched for mice and dog retinal disorders.

Stage I
-------

Several studies have stressed the importance of oxidative stress for photoreceptors in RP \[[@r5],[@r10]\]. The IHR database was built upon experiments using recirculation and reoxygenation of the brain after ischemia, which leads to oxidative stress. If genes related to oxidative stress are an intrinsic part of the database, correlations with retinal genes may arise from oxidative stress. To estimate this contribution, an additional database specific for the genomic response to oxidative stress was generated based on the transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) \[[@r46]\]. NRF2 mediates the response to oxidative stress by binding to the antioxidant response element (ARE). Wang et al. recently provided databases of NRF2-target genes \[[@r46]\]. The NRF2-ARE related databases were then scanned for retinal disorders (as in Stage C) and for genes related to pre-mRNA splicing (as in Stage D).

Results
=======

Stage A: Database of ischemia-hypoxia response genes of the brain
-----------------------------------------------------------------

About 2,500 gene entries were collected from 24 microarray studies of ischemia-hypoxia in the brain. Using the clone ID number, we found about 1,750 genes could be linked to a gene symbol, forming the IHR gene list. Of these, 78% genes were only found once and 22% were found two or more times. The IHR genes made up 7% of all genes. The genes listed in a study of retinal ischemia \[[@r34]\] overlapped by about 40% with the genes in the IHR gene list obtained in the brain. This comparison provides proof of principle that many genes studied in the brain are likely to be involved in the retina under conditions of abnormal oxygenation \[[@r35]\].

Stage B: Brain expression of ubiquitously expressed *retinitis pigmentosa* genes
--------------------------------------------------------------------------------

The expression profile of the RP genes with global expression listed in the review of Pacione et al. \[[@r14]\] and of two additional genes (*CA4* \[[@r39]\], *SEMA4A* \[[@r40]\]) was examined by using transcriptome information from UniGene. Expression in the brain was listed for *RP9/PAP1, IMPDH1, MERTK, RPGR, RP2, CHM, TIMP3, PRPF3, PRPF8, PRPF31, SEMA4A* and *CA4*. Thus, a database established in the brain is suitable to explore features of regulation for these RP genes.

Stage C: Ischemia-hypoxia response genes related to *retinitis pigmentosa* and other retinal dystrophies
--------------------------------------------------------------------------------------------------------

When probing the IHR gene list, several genes related to RP and retinal dystrophies presented as ischemia-hypoxia regulated. *CNGB1* is mutated in autosomal recessive retinitis pigmentosa (ARRP, OMIM [600724](http://www.molvis.org/molvis/external.cgi?omim=600724)) and is expressed in the brain (UniGene Hs.147062), where it was found regulated in ischemia \[[@r47]\]. Mutations of *SEMA4A* were found in RP35 (OMIM [610282](http://www.molvis.org/molvis/external.cgi?omim=610282)) and in dominant cone-rod dystrophy (CRD; listed in RISN) \[[@r39]\], *SEMA4A* is ischemia regulated in the brain \[[@r48]\]. *RRG4* mRNA (*UNC119 - HRG4*) was found down-regulated after neonatal brain ischemia/hypoxia \[[@r49]\], and mutations in this gene cause a rare form of cone-rod dystrophy - CRD (OMIM [604011](http://www.molvis.org/molvis/external.cgi?omim=604011)) \[[@r50]\]. *SOX2* mutations cause anophthalmia (OMIM [184429](http://www.molvis.org/molvis/external.cgi?omim=184429)) and brain malformations \[[@r51],[@r52]\]. *Sox2* is down-regulated in brain ischemia \[[@r48]\].

Stage D: Ischemia-hypoxia response genes in the U4/U6.U5 tri-snRNP complex
--------------------------------------------------------------------------

Our analysis focused on genes involved in pre-mRNA splicing due to the unique situation that four RP genes with global expression contribute to one functional protein complex. Hypoxia regulation of genes interacting with RP genes within the same protein complex may exert an indirect effect of oxygenation. There were 37 genes related to mRNA processing on the IHR gene list and in publications on HIF targets in neurons \[[@r37],[@r38]\]. When gene products were examined for a specific role in the U4/U6.U5 tri-snRNP complex, four genes were identified. A complete expression listing of genes from brain involved in mRNA processing or under hypoxia regulation is still not not available. Therefore, an enrichment of hypoxia controlled genes among the mRNA processing genes cannot be accurately determined. The following estimate can be made. Based on data by Pacione et al. \[[@r14]\], 30 genes out of all genes (ca. 28,000) code for the protein components of the U4/U6.U5 tri-snRNP complex. Thus, among the n=1,750 genes of IHR gene database, two genes could be related to the U4/U6.U5 tri-snRNP complex by chance, whereas four genes were observed.

The first gene was precursor mRNA-processing factor 4 (*PRPF4*) which was found upregulated in global brain ischemia \[[@r53]\]. The presence of PRPF4 in U4/U6.U5 tri-snRNPs has been described whereby PRPF4 was tightly associated with U4/U6 snRNP \[[@r54],[@r55]\]. PRPF4 binds to the central region of PRPF3 (causing RP18), and PRPF3 may recruit PRPF4 for the U4/U6 snRNP assembly \[[@r56]\].

The second gene found was *SART1*, human squamous cell carcinoma antigen recognized by T cells 1 \[[@r57]\]. This gene was reported to be down-regulated in a rat model of neonatal ischemia/hypoxia of the brain \[[@r49]\]. Human *SART1* (GeneID 9092; OMIM [605941](http://www.molvis.org/molvis/external.cgi?omim=605941)) has been also characterized as the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP \[[@r43]\], which is critically important for the recruitment of the U4/U6.U5 tri-snRNP complex to the pre-spliceosome \[[@r43]\]. Additional information for *SART1* and a role in hypoxia was found. The original data set of our cDNA microarray study in brain ischemia \[[@r36]\] showed a trend for down-regulation of the mouse *Sart1* mRNA (−1.5) that was measured with the probe sequence [AA607769](http://www.molvis.org/molvis/external.cgi?gbdna=AA607769) (Nucleotide, NCBI). A BLAST search of the probe sequence ([AA607769](http://www.molvis.org/molvis/external.cgi?gbdna=AA607769)) showed 97% identity with clone AF129931.1 which was listed as "mus musculus hypoxia associated factor (Haf)" while being linked to *Sart1* in GeneID 20227 (Entrez Gene, NCBI). By following the term "hypoxia associated factor (Haf)" in the original literature, we found HAF was originally characterized during the analysis of the hypoxia induced expression of EPO and vascular endothelial growth factor (VEGF) under hypoxic conditions \[[@r42],[@r58]\].

The third gene was *LSM8*, U6 snRNA-associated Sm-like protein, which was down-regulated in focal ischemia in mice \[[@r48]\]. Achsel et al. \[[@r59]\] showed that the so-called LSm proteins (which are related to the "Sm" proteins binding to the Sm site of small nuclear RNAs) facilitate the formation of U4/U6 duplexes.

The fourth gene was *Pim1*, which was found to be strongly upregulated in an extended analysis of our microarray study \[[@r36]\]. Pim1 binds to PAP1 \[[@r60]\], the gene carrying mutations in RP9 \[[@r22]\], which, in turn, contributes to the U4/U6.U5 tri-snRNP complex \[[@r23],[@r24]\].

Stage E: Expression information for selected genes
--------------------------------------------------

Homo sapiens *PRPF4* mRNA was found in the NEI "human retina non-normalized" database (NbLib0042); and clone [XM_131444](http://www.molvis.org/molvis/external.cgi?gbdna=XM_131444) was linked to *Prpf4* in the "dbEST mouse retina (non-normalized) data collection" (NbLib0027). Expression of *SART1* (clone [AF353625](http://www.molvis.org/molvis/external.cgi?gbdna=AF353625)) was detected in the dbEST human retina list. Gene expression profiling using SAGE provided evidence for *Sart1* mRNA expression in the mouse retina and in the microdissected outer nuclear layer \[[@r41]\]. Expression of *LSM8* mRNA was listed for the eye in UniGene (Hs.446179) but not in NEIBank. A subsequent search in EyeBrowse showed an alignment of eye ESTs to the human genome sequence for *PRPF4* (retina, BQ638822), *SART1* (retina, W27222; RPE, BM694274), and *PIM1* (RPE, CA390708).

Stage F: Putative target genes for SART1/HAF
--------------------------------------------

HAF regulation has been shown for *EPO* and *VEGF* \[[@r42],[@r58]\]. These genes are involved in retinal pathology. Therefore, additional genes regulated by HAF could be relevant to retinal function and pathology. Targets of SART1/HAF regulation were trapped using the EP17 consensus sequence for HAF binding in the promoter of the EPO gene \[[@r42]\] in a BLAST search for "short nearly exact matches." Ten annotated genes had matches in putative regulatory regions (i.e., outside protein coding sequences). Two of these putative HAF target genes were of interest for retinal degenerations: (a) Mm. ATPase, Na^+^/K+ transporting, beta 2 polypeptide (*Atp1b2*) was known originally as AMOG-glial cell adhesion molecule (16/17 matches, [NM_031415](http://www.molvis.org/molvis/external.cgi?gbdna=NM_031415), 3′ UTR), and disruption of *Amog* in mice leads to apoptotic cell death of photoreceptors \[[@r61]\]; and (b) Neuroblastoma, suppression of tumorigenicity (*Nbl1*, "DAN"; 16/17 matches, [NM_008675](http://www.molvis.org/molvis/external.cgi?gbdna=NM_008675), 3′ UTR) is known to be regulated by brain ischemia and is expressed in the eye.

Stage G: Immunohistochemical study
----------------------------------

Immunoreactivity for the 110 kDa SR-related protein was found in all retinal cells of the cynomolgus monkey ([Figure 1](#f1){ref-type="fig"}). Strong labeling with a fine granular pattern was obtained in the nucleus of retinal ganglion cells (RGCs). The cytoplasm of large RGCs also showed immunoreactivity. Nuclei of neurons of the inner nuclear layer were positive. Strong expression was found in the nuclei of photoreceptors and in the inner segments, whereas the outer segments were negative. Nuclei of the retinal pigment epithelium (RPE), vascular cells, and optic nerve glial cells were also labeled. Specific labeling was absent after omission of the primary antibody and after absorption of the primary antibody with the native peptide. Subsequently, sections of a human retina were labeled, using the ABC technique for detection ([Figure 2](#f2){ref-type="fig"}). The staining pattern obtained in the human retina was identical to that seen for the monkey retina. Staining of the nucleus was seen for RGCs and cells in the inner nuclear layer. The nuclei and the inner segments of photoreceptors showed immunoreactivity whereas the outer segments were unlabeled. The RPE and choroidal vessels could not be evaluated due to the presence of pigment. All immunostaining was absent in absorption controls. A fine band of labeling was seen in the OPL of the primate and human retinas ([Figure 1](#f1){ref-type="fig"} and [Figure 2](#f2){ref-type="fig"}), which remains unexplained, because generalized staining indicative of expression in synapses or other small organelles was not found. This raises the question whether splicing proteins can be localized to the specialized dendrites of the axonless horizontal cells in OPL.

![Immunostaining for 110 kDa SR-related protein in cynomolgus monkey retina. Immunohistochemical detection of the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP (hypoxia-associated factor) in paraffin sections of the cynomolgus monkey retina. **A**: View of the central retina; **B**: view of the peripheral retina. Note that the dark signal in the retinal pigment epithelium (RPE) and choroid derives from the melanin. These areas were included in the image to illustrate the total absence of specific immunolabeling from the outer segments. The following abbreviations were used in this figure: ganglion cell layer (GCL); inner nuclear layer (INL); inner plexiform layer (IPL); inner segments of photoreceptors (IS); outer nuclear layer (ONL); outer segments of photoreceptors (OS); retinal pigment epithelium (RPE). The calibration bar is equal to 40 μm.](mv-v14-125-f1){#f1}

![Immunostaining for 110 kDa SR-related protein in human retina. Immunohistochemical detection of the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP (hypoxia-associated factor) was carried out in paraffin sections of the peripheral human retina. The dark signal in the retinal pigment epithelium (RPE) and choroid derives from the melanin. These areas were included in the image to illustrate the total absence of specific immunolabeling from the outer segments. **A**: Distinct cellular labeling was obtained with the antibody to 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP. **B**: Immunoreactivity was absent after absorption of the primary antibody with immunogenic peptides. The following abbreviations were used in this figure: ganglion cell layer (GCL), inner nuclear layer (INL), inner plexiform layer (IPL), outer plexiform layer (OPL), inner segments of photoreceptors (IS), outer nuclear layer (ONL), and outer segments of photoreceptors (OS). The calibration bar is equal to 40 μm.](mv-v14-125-f2){#f2}

Stage H: Links between splicing and additional forms of retinitis pigmentosa
----------------------------------------------------------------------------

Several RP genes remain to be identified. The loci for the hypoxia-regulated genes related to the U4/U6.U5 tri-snRNP complex by our analysis (*PRPF4, SART/HAF1, LSM8*, *PIM1*) were scanned in OMIM and RetNet. *SART1/HAF* is on 11q13, where a locus for the autosomal dominant neovascular inflammatory vitreoretinopathy (VRNI) was mapped (OMIM 193235). VRNI is a blinding disorder that presents with some clinical features of RP. The mouse or dog orthologs did not map to loci containing novel retinal disorders.

Stage I: Exploring a role for gene regulation by oxidative stress
-----------------------------------------------------------------

Since several studies have stressed the importance of oxidative stress for photoreceptors in RP \[[@r5],[@r10]\], the databases provided by Wang et al. \[[@r46]\] for the genomic response to oxidative stress were examined. Combining the data provided by Wang et. (supplemental tables 2 and 3 in Wang et. paper) \[[@r46]\]; n=674 putative putative NRF2- target genes were available for analysis which were scanned for genes related to retinal disorders. Matches were found for *CACNA1F* (Night Blindness, congenital, stationary, X-linked, Type 2- CSNB2; OMIM [300071](http://www.molvis.org/molvis/external.cgi?omim=300071)), *GNAT1* (Night Blindness, congenital, stationary, autosomal dominant 3-CSNBAD3; OMIM [610444](http://www.molvis.org/molvis/external.cgi?omim=610444)), *RHO* (Retinitis pigmentosa 4-RP4; OMIM [180380](http://www.molvis.org/molvis/external.cgi?omim=180380); also, Night Blindness, congenital, stationary, autosomal dominant 1-CSNBAD1; OMIM [610445](http://www.molvis.org/molvis/external.cgi?omim=610445)), and *OAT* (Gyrate atrophy; OMIM [258870](http://www.molvis.org/molvis/external.cgi?omim=258870)). We reencountered *PIM1* and *SEMA4A*, suggesting a role of oxidative stress for the regulation of these two matched IHR genes. When looking for additional genes related to the U4/U6.U5-tri-SNP, no genes were found in the list of fully annotated NRF2 target genes (n=412) that were provided by Wang et al. (supplemetal table 2 in Wang et. paper) \[[@r46]\]. This negative finding indirectly suggests that the correlations found at stage D are due to a hypoxic component which is in line with the original hypothesis.

Discussion
==========

Cyclical changes between light and dark are associated with considerable physiological changes in oxygen levels at the level of the outer retina \[[@r1],[@r2]\]. Therefore, excessive metabolic stress in photoreceptors could be expected to create specific localized problems resulting in RP forms that involve widely expressed genes, e.g., genes involved in dysfunction of pre-mRNA splicing. To estimate which genes could be regulated by variable oxygenation in the retina, we applied a comparative analysis of gene expression under experimental ischemic-hypoxic conditions in the brain, based on the hypothesis that similar genes are regulated in the brain and retina. The hypothesis was supported by the similarity between changes seen in the brain and the retina after ischemia \[[@r6]\] and by the evaluation of gene expression profiles in one study on the ischemic retina \[[@r34]\]. Several genes related to RNA processing turned out to be regulated after ischemia-hypoxia in the brain, and, four genes could be specifically related to the U4/U6.U5 tri-snRNP. Database searches showed that these genes were also likely to be expressed in the retina.

The first gene found was *PRPF4*. The PRPF4 protein binds to the central region of PRPF3. Because mutations in *PRPF3* cause RP18 \[[@r21]\] and PRPF3 interacts with PAP1 (causing RP9), a strong hypothetical link to ischemia-hypoxia (oxygenation) involvement in ADRP emerged from the present analysis. The second IHR gene was the 110 kDa SR-related protein of the U4/U6.U5 tri-snRNP, also known as *SART1* or *HAF* \[[@r42],[@r43],[@r57]\]. Immunohistochemistry verified expression in photoreceptors of the primate and human retina. Dual functions of proteins in transcriptional regulation and pre-mRNA splicing have been recognized \[[@r62]\]. Accordingly, the 110 kDa SR-related protein is essential for the recruitment of the U4/U6.U5 tri-snRNP complex to the spliceosome \[[@r43]\], and the same protein plays a role in the regulation of expression of *EPO* and *VEGF* by hypoxia under the name of HAF \[[@r42],[@r58]\]. Intriguingly, EPO showed protective functions for photoreceptors \[[@r63]\]. In the photoreceptor layer, intrinsic physiological changes in oxygenation \[[@r2]\] could control the activity of the SART1/HAF which in turn affects the expression as well as the splicing of specific target genes, e.g., *EPO*, *VEGF*, *Atp1b2*, and *Nbl1*. The *LSM8* gene can be also set in the context of the U6 complex \[[@r59]\]. The fourth gene found regulated in the brain, *PIM1*, targets PAP1 (causing RP9) for phosphorylation in vitro \[[@r60]\]. A 2004 study showed that the interaction between PAP1 and PIM1 does not play a major role in vivo \[[@r23]\], so it remains to be seen whether PAP1 is indirectly regulated by oxygenation.

Regulation of *PRPF4*, *SART1*/*HAF*, *LSM8, and PIM1* by changes in oxygenation argues for a reversible functional change within the U4/U6.U5 tri-snRP complex, which could be especially important for photoreceptors where oxygenation and oxygen consumption follow a circadian rhythm. Mutations in any of the four ADRP genes involved in the assembly of the U4/U6.U5 tri-snRP complex, i.e., *PRPF31* (RP11), *PRPF8* (RP13), *PRPF3* (RP18), and *PAP1* (RP9), may influence either the ability to undergo this change or its reversibility. If the U4/U6.U5 tri-snRP complex is already impaired by mutations in any of the four genes causing ADRP, it may be unable to deal with the physiological changes of oxygenation which are mediated by the four hypoxia-regulated proteins emerging in this study. A dominant negative effect is not supported by this mechanism as well not by the late onset of ADRP in the patients. Therefore, a reduced function of the U4/U6.U5 tri-snRP complex under hypoxic conditions will cause an alternating haploinsufficiency during the diurnal rhythm, which exerts a slow, persisting damage to the photoreceptor cells, resulting in late onset disease. However, it should be noted that the correlations found here cannot be taken to indicate an exclusive importance of hypoxia for the U4/U6.U5 tri-snRNP as compared to other protein complexes. Analysis of other components of the spliceosome may be fruitful.

Oxidative stress has been considered to be a major factor in retinal degeneration \[[@r5],[@r10]\]. Our analysis has stressed "hypoxia" throughout, but it should be noted that hypoxia and oxidative stress are closely associated. It has been argued that photoreceptors are optimally stable in hypoxia, and are destabilized by both hypoxia and hyperoxia \[[@r64]\].

In fact, the IHR gene database contains multiple genes from the brain subjected to reoxygenation when profound oxidative stress occurs \[[@r36]\]. We surveyed databases from a recent bioinformatics study \[[@r46]\] to probe for a specific contribution of antioxidant genes, whose function is to counteract oxidative stress. *PIM1* was the only gene with a role in pre-mRNA splicing found to match. This comparison renders it more likely that hypoxia and metabolic stress were involved. There is an oxygen sink on the promixal side on the inner segment and outer nuclear layer where the gene products of the ADRPs related to pre-mRNA splicing should play important roles \[[@r2]\]. Furthermore, the initial loss of photoreceptors in RP may lead to an alleviation of the physiological hypoxia and relative hyperoxia \[[@r65]\].

More than 40% of cases of ADRP could not be linked to known mutations \[[@r66]\], and novel genes may also relate to pre-mRNA splicing. For the RP33 locus, *ASCC3L1*, also known as U5 snRNP-specific protein, was already suggested as a candidate gene \[[@r67]\].

Interestingly, known RP genes may play a larger role in the nucleus than is presently recognized. The (recessive) RP26 gene encodes ceramide kinase-like protein (*CERKL*) which was linked to nuclear functions. As noted by Inagaki et al. \[[@r68]\] proteins encoded by (dominant or recessive) RP1 and (recessive) RP14 are known to be localized to the nucleolus \[[@r68]\]. Yoon and colleagues showed that the *RP2* gene product undergoes re-localization into the nucleus upon treatment of cells with DNA damaging agents inducing oxidative stress, most notably solar simulated light and UVA radiation, and proposed a previously unrecognized role as a DNA damage response factor and 3′ to 5′ exonuclease \[[@r69]\]. Inosine monophosphate dehydrogenase type I (*IMPDH1*) mutations in RP10 (OMIM [146690](http://www.molvis.org/molvis/external.cgi?omim=146690)) may influence the binding of the protein to single stranded nucleic acids \[[@r70]\].

The concept of an influence of oxygenation on gene expression and function of a protein machinery is only one of several explanations for selective vulnerability of photoreceptors in RP forms that involve widely expressed RP genes. Other possible explanations include strong differences in expression across different organs or even the presence of retina-specific splice variants \[[@r16]\]. Nevertheless, changes in gene expression and function due to strong local changes in oxygenation may relate to the clinically variable and delayed manifestation of ADRP. Hypoxia has already been implicated in the variable clinical manifestation of *RP1* \[[@r14],[@r71]\]. Two of the ADRP forms related to pre-mRNA splicing show variable clinical expression, which could hint at a gene-environment interaction. Large variations in retinal dysfunction across family members with RP9 have been reported \[[@r14],[@r72]\], and RP11 caused by *PRPF31* mutations shows generation skipping \[[@r26],[@r27],[@r66]\]. It will be important to examine the critical threshold concentrations for the respective proteins. Based on the findings in this paper, we feel there is a need for further studies of genes related to the U4/U6.U5 tri-snRNP, using retinal tissue under ischemic-hypoxic conditions.
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